title: Pancarcinoma T/Tn antigen detects human carcinoma long before biopsy does and its vaccine prevents breast carcinoma recurrence.
authors.affiliation: H. M. Bligh Cancer Research Laboratories, Chicago Medical School, Illinois 60064.
authors.forename: G F
authors.initials: GF
authors.lastname: Springer
authors.forename: P R
authors.initials: PR
authors.lastname: Desai
authors.forename: H
authors.initials: H
authors.lastname: Tegtmeyer
authors.forename: B D
authors.initials: BD
authors.lastname: Spencer
authors.forename: E F
authors.initials: EF
authors.lastname: Scanlon
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000276:immunology*; D001706:Biopsy; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002277:Carcinoma / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D016233:Immunotherapy, Active; D013997:Time Factors
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; C040286:Tn antigen; C016467:Thomsen-Friedenreich antigen